Cargando…
RTA‐408 protects against propofol‐induced cognitive impairment in neonatal mice via the activation of Nrf2 and the inhibition of NF‐κB p65 nuclear translocation
OBJECTIVE: To explore the effect of RTA‐408 on the propofol‐induced cognitive impairment of neonatal mice via regulating Nrf2 and NF‐κB p65 nuclear translocation. METHODS: C57BL/6 neonatal mice were randomized into intralipid, propofol, vehicle + propofol, and RTA‐408 + propofol groups. The learning...
Autores principales: | Zhang, Ling, Zhou, Qian, Zhou, Chun‐Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821557/ https://www.ncbi.nlm.nih.gov/pubmed/33295701 http://dx.doi.org/10.1002/brb3.1918 |
Ejemplares similares
-
The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-κb signaling
por: Sun, Xuewu, et al.
Publicado: (2019) -
Variable effects of omaveloxolone (RTA408) on primary fibroblasts with mitochondrial defects
por: Zighan, Madleen, et al.
Publicado: (2022) -
Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers
por: Reisman, Scott A., et al.
Publicado: (2015) -
RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
por: Probst, Brandon L., et al.
Publicado: (2015) -
RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene
por: Han, Peng, et al.
Publicado: (2017)